Mark A. Wright
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- T-cell and B-cell Immunology
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Immunology 27
- Immunotherapy and Immune Responses 24
- Immune Cell Function and Interaction 11
- Immune cells in cancer 8
- Immune Response and Inflammation 5
- Oncology 18
- Cancer Immunotherapy and Biomarkers 6
- Cancer Cells and Metastasis 5
- Chemokine receptors and signaling 4
- Co-authors
- Matthew R. Young (24 shared papers)M. Rita I. Young (13 shared papers)Margaret Prechel (10 shared papers)Yvonne Lozano (15 shared papers)Melvin E. Young (8 shared papers)Janet Benefield (5 shared papers)Sonia Collins (1 shared paper)G J Petruzzelli (1 shared paper)
- Journals
- International Journal of Cancer (10 papers)Cancer Immunology Immunotherapy (8 papers)Cancer Letters (2 papers)The Journal of Immunology (2 papers)Clinical & Experimental Metastasis (2 papers)
- Partner nations
- United StatesAustraliaSpain
In The Last Decade
Mark A. Wright
40 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 85
- Immunology 1.1k
- Oncology 733
- Biological Psychiatry 53
- Otorhinolaryngology 49
- Cancer Research 142
Countries citing papers authored by Mark A. Wright
This map shows the geographic impact of Mark A. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Wright more than expected).
Fields of papers citing papers by Mark A. Wright
This network shows the impact of papers produced by Mark A. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Wright. The network helps show where Mark A. Wright may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Wright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor. | 1995 | 247 |
| 2 | 1996 | 163 | |
| 3 | 1997 | 144 | |
| 4 | 1996 | 127 | |
| 5 | 1997 | 99 | |
| 6 | Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin. | 1993 | 86 |
| 7 | 1997 | 77 | |
| 8 | 1995 | 63 | |
| 9 | Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis. | 1992 | 53 |
| 10 | 1992 | 50 | |
| 11 | 1991 | 49 | |
| 12 | 2000 | 45 | |
| 13 | 1992 | 44 | |
| 14 | 1999 | 41 | |
| 15 | Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants. | 1990 | 33 |
| 16 | 1990 | 33 | |
| 17 | Inhibition of tumor production of granulocyte-macrophage colony-stimulating factor by 1 alpha, 25-dihydroxyvitamin D3 reduces tumor motility and metastasis. | 1993 | 31 |
| 18 | Stimulation of immune-suppressive bone marrow cells by colony-stimulating factors. | 1990 | 30 |
| 19 | 1995 | 30 | |
| 20 | 1996 | 30 |
About Mark A. Wright
Mark A. Wright is a scholar working on Immunology, Oncology, Biotechnology, Endocrine and Autonomic Systems and Molecular Biology, having authored 41 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (24 papers), Immune Cell Function and Interaction (11 papers), Cancer Research and Treatments (8 papers), Immune cells in cancer (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cancer Cells and Metastasis (5 papers), Immune Response and Inflammation (5 papers) and Chemokine receptors and signaling (4 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (733 citations), Biological Psychiatry (53 citations), Otorhinolaryngology (49 citations) and Cancer Research (142 citations). Mark A. Wright has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Matthew R. Young, M. Rita I. Young, Margaret Prechel, Yvonne Lozano, Melvin E. Young, Janet Benefield, Sonia Collins, G J Petruzzelli, John P. Matthews and Michael P. Coogan. Their work appears in journals such as International Journal of Cancer, Cancer Immunology Immunotherapy, Cancer Letters, The Journal of Immunology and Clinical & Experimental Metastasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.